| Sex differences in drug use among polysubstance users B Lewis, LA Hoffman, SJ Nixon Drug and alcohol dependence 145, 127-133, 2014 | 84 | 2014 |
| Characterizing chronic pain and alcohol use trajectory among treatment-seeking alcoholics J Boissoneault, B Lewis, SJ Nixon Alcohol 75, 47-54, 2019 | 79 | 2019 |
| Race and socioeconomic status in substance use progression and treatment entry B Lewis, L Hoffman, CC Garcia, SJ Nixon Journal of ethnicity in substance abuse 17 (2), 150-166, 2018 | 77 | 2018 |
| Characterizing gender differences in treatment seekers B Lewis, SJ Nixon Alcoholism: Clinical and Experimental Research 38 (1), 275-284, 2014 | 67 | 2014 |
| Agmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposure B Lewis, KA Wellmann, S Barron Pharmacology Biochemistry and Behavior 88 (1), 114-121, 2007 | 56 | 2007 |
| Topiramate (Topamax) reduces conditioned abstinence behaviours and handling-induced convulsions (HIC) after chronic administration of alcohol in Swiss-Webster mice JM Farook, DJ Morrell, B Lewis, JM Littleton, S Barron Alcohol & Alcoholism 42 (4), 296-300, 2007 | 50 | 2007 |
| Sex differences in alcohol-related neurobehavioral consequences SJ Nixon, R Prather, B Lewis Handbook of clinical neurology 125, 253-272, 2014 | 49 | 2014 |
| Severe deficit in brain reward function associated with fentanyl withdrawal in rats AW Bruijnzeel, B Lewis, LK Bajpai, TE Morey, DM Dennis, M Gold Biological psychiatry 59 (5), 477-480, 2006 | 48 | 2006 |
| Effects of mecamylamine on alcohol consumption and preference in male C57BL/6J mice JM Farook, B Lewis, JG Gaddis, JM Littleton, S Barron Pharmacology 83 (6), 379-384, 2009 | 37 | 2009 |
| Lobeline, a nicotinic partial agonist attenuates alcohol consumption and preference in male C57BL/6J mice JM Farook, B Lewis, JG Gaddis, JM Littleton, S Barron Physiology & behavior 97 (3-4), 503-506, 2009 | 36 | 2009 |
| Neurophysiological and interpersonal correlates of emotional face processing in alcohol use disorder LA Hoffman, B Lewis, SJ Nixon Alcoholism: Clinical and Experimental Research 43 (9), 1928-1936, 2019 | 33 | 2019 |
| Agmatine reduces ultrasonic vocalization deficits in female rat pups exposed neonatally to ethanol K Wellmann, B Lewis, S Barron Neurotoxicology and teratology 32 (2), 158-163, 2010 | 33 | 2010 |
| Cognitive training as a component of treatment of alcohol use disorder: A review. SJ Nixon, B Lewis Neuropsychology 33 (6), 822, 2019 | 32 | 2019 |
| Emotional face processing among treatment-seeking individuals with alcohol use disorders: Investigating sex differences and relationships with interpersonal functioning B Lewis, JL Price, CC Garcia, SJ Nixon Alcohol and Alcoholism 54 (4), 361-369, 2019 | 32 | 2019 |
| The roles of phosphatidylethanol, ethyl glucuronide, and ethyl sulfate in identifying alcohol consumption among participants in professionals health programs GM Reisfield, SA Teitelbaum, SO Opie, J Jones, DG Morrison, B Lewis Drug testing and analysis 12 (8), 1102-1108, 2020 | 28 | 2020 |
| Topiramate attenuates the stress-induced increase in alcohol consumption and preference in male C57BL/6J mice JM Farook, B Lewis, JM Littleton, S Barron Physiology & behavior 96 (1), 189-193, 2009 | 27 | 2009 |
| Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice JM Farook, A Krazem, B Lewis, DJ Morrell, JM Littleton, S Barron Physiology & behavior 95 (1-2), 267-270, 2008 | 26 | 2008 |
| Neurophysiological correlates of moderate alcohol consumption in older and younger social drinkers B Lewis, J Boissoneault, R Gilbertson, R Prather, SJ Nixon Alcoholism: Clinical and Experimental Research 37 (6), 941-951, 2013 | 24 | 2013 |
| Effects of acute alcohol and driving complexity in older and younger adults JL Price, B Lewis, J Boissoneault, IR Frazier, SJ Nixon Psychopharmacology 235, 887-896, 2018 | 21 | 2018 |
| Polyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependence S Barron, B Lewis, K Wellmann, M Carter, J Farook, J Ring, ... Recent Patents on CNS Drug Discovery (Discontinued) 7 (2), 129-144, 2012 | 20 | 2012 |
